Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Accelevir Diagnostics, LLC in July, 2021 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI165128-01 | Phase I | 300,000 | July 7, 2021 | |||||||
A SBIR Phase I contract was awarded to Accelevir Diagnostics, LLC in December, 2019 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI149816-01 | Phase I | 300,000 | December 12, 2019 | |||||||
A SBIR Phase I contract was awarded to Accelevir Diagnostics, LLC in July, 2021 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI165126-01 | Phase I | 300,000 | July 23, 2021 | |||||||
A SBIR Phase II contract was awarded to Accelevir Diagnostics, LLC in January, 2018 for $2,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AI124996-02 | Phase II | 2,000,000 | January 1, 2018 | |||||||
A SBIR Phase I contract was awarded to Accelevir Diagnostics, LLC in August, 2018 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI142866-01 | Phase I | 300,000 | August 15, 2018 | |||||||
A SBIR Phase I contract was awarded to Accelevir Diagnostics, LLC for $299,975.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N93020C00015 | Phase I | 299,975 | ||||||||
A SBIR Phase I contract was awarded to Accelevir Diagnostics, LLC in August, 2017 for $288,740.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI131900-01A1 | Phase I | 288,740 | August 18, 2017 | |||||||
A SBIR Phase I contract was awarded to Accelevir Diagnostics, LLC in June, 2016 for $259,322.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI124996-01A1 | Phase I | 259,322 | June 27, 2016 | |||||||
A SBIR Phase I contract was awarded to Accelevir Diagnostics, LLC in August, 2017 for $297,200.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI131826-01 | Phase I | 297,200 | August 1, 2017 | |||||||
A SBIR Phase I contract was awarded to Accelevir Diagnostics, LLC in July, 2016 for $224,552.0 USD from the National Science Foundation. | SBIR | 1621633 | Phase I | 224,552 | July 1, 2016 | |||||||
A SBIR Phase II contract was awarded to Accelevir Diagnostics, LLC in September, 2017 for $500,000.0 USD from the National Science Foundation. | SBIR | 1738428 | Phase II | 500,000 | September 15, 2017 | |||||||
A SBIR Phase II contract was awarded to Accelevir Diagnostics, LLC for $2,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N93023C00017 | Phase II | 2,000,000 |